Stocks and InvestingStocks and Investing
Mon, June 26, 2023
Fri, June 23, 2023
Thu, June 22, 2023
Wed, June 21, 2023

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $23 on, Jun 21st, 2023


Published on 2024-10-28 04:26:08 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $23 on, Jun 21st, 2023.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Leland Gershell of "Oppenheimer" Reiterated at Buy and Held Target at $22 on, Monday, May 15th, 2023